SEC Form 4 · accession 0001400482-16-000199
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD · M??????
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lukas Scheibler
Officer — EVP of Research & Development
Period of report
Jul 12, 2016
Accepted (ET)
Jul 14, 2016 · 7:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001400482
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1,F2 | $15.41 | Jul 12, 2016 | A | 32,445 | A | — | Jul 12, 2026 | Common Stock | 32,445 | 32,445 | D |
| Non-Qualified Stock Option (right to buy)F1,F2 | $15.41 | Jul 12, 2016 | A | 87,555 | A | — | Jul 12, 2026 | Common Stock | 87,555 | 87,555 | D |
Explanation of responses
- F16.25% of the total options granted (both incentive and non-qualified) vest on September 1, 2016 with the remaining options vesting monthly on a pro rata basis that will commence on October 1, 2016 and will continue until June 1, 2020, at which time all of the options will be fully vested, subject to the reporting person's continued employment with the issuer on each vesting date.
- F2The issuer's common stock trades on the Tokyo Stock Exchange under the symbol referenced in the issuer's registration statement on Form S-1 (File No. 333-192900).